MELISSA STEINER: Open Payments
NPI 1588994370 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$962 in 54 payments from 13 companies in 2025. Trend: 2023 $1,583 · 2024 $1,285 · 2025 $962
Food & beverage: $962
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $184 |
| Amgen Inc. | 9 | $152 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $126 |
| HEARTFLOW, INC. | 6 | $122 |
| Boston Scientific Corporation | 4 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $81 |
| MEDICOMP INC | 3 | $54 |
| Novo Nordisk Inc | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Abbott Laboratories | 1 | $24 |
Products named: CAMZYOS, Repatha, LifeVest, FFRct, JARDIANCE, CDS - MCT/CEM Monitoring, TELEPATCH CARDIAC MONITOR, Wegovy.
Industry payments across PA — which companies pay providers there.
